Publications found:
579,906
Sort by:
Global Iclusig Market Research Report 2024, Forecast to 2032
US$ 3,400.00
Report Overview Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(AL...
October 2024
100 pages